GlobeNewswire by notified

C.K. McWhorter Moves Forward With Elite Luxury Wellness Chateaus & Resorts With Integration of Quantum Computing and Cutting-Edge Technology


GENEVA, Switzerland, April 01, 2024 (GLOBE NEWSWIRE) -- C.K. McWhorter & McWhorter Family Trust, a beacon of luxury and innovation in the investment world, moves forward with a visionary initiative to revolutionize the luxury wellness chateaus & resort experience through the integration of quantum computing and cutting-edge technology. This strategic endeavor represents a bold leap forward in the realms of luxury hospitality and wellness, where tradition meets innovation to create unparalleled experiences for discerning guests.

At the heart of this initiative is the Trust's commitment to redefining luxury wellness through a fusion of timeless elegance and technological innovation. By leveraging quantum computing and luxury tech, the Trust aims to elevate every aspect of the luxury wellness experience, from personalized treatments to sustainable operations.

The Family’s luxury wellness chateaus will serve as the epitome of sophistication and serenity, offering guests an immersive journey into the realm of holistic well-being & refinement. Here's how quantum computing and luxury tech will be seamlessly integrated into the luxury wellness chateaus:

  • Personalized Wellness Experiences: Quantum algorithms will analyze guests' unique biometric data and preferences to tailor bespoke wellness programs that address their individual needs and goals. From personalized nutrition plans to customized spa treatments, guests will enjoy a truly personalized journey to wellness.
  • State-of-the-Art Health Monitoring: Advanced health monitoring devices equipped with quantum-inspired sensors will continuously track guests' vital signs and wellness metrics in real-time. This data will be analyzed using quantum computing algorithms to provide insights into guests' overall health and well-being, enabling proactive interventions when necessary.
  • Sustainable Operations: Quantum-inspired design principles and energy-efficient technologies will be integrated into the chateaus' infrastructure to minimize environmental impact and maximize sustainability. From renewable energy sources to eco-friendly building materials, the chateaus will exemplify the Trust's commitment to environmental stewardship.
  • Immersive Wellness Technologies: Cutting-edge wellness technologies, powered by quantum computing and luxury tech, will enhance guests' sensory experiences and promote relaxation and rejuvenation. From immersive virtual reality meditation sessions to personalized aroma therapy infused with quantum-inspired scents, guests will immerse themselves in a world of unparalleled luxury and tranquility.

"Our luxury wellness chateaus represent the pinnacle of luxury hospitality and wellness," said Carter McWhorter , "By integrating quantum computing and cutting-edge technology into every aspect of the guest experience, we are redefining what it means to indulge in elite level luxury health & wellness experiences.”

The Ultra-Elite Wellness Chateau Collection is poised to attract a prestigious clientele consisting of Sovereigns, Elite Business Executives , Elite Athletes, Elite Families, and Esteemed Individuals from around the globe as well as selected philanthropically sponsored scholars & youth. With a discerning taste for luxury and a keen interest in holistic well-being, these guests seek an unparalleled experience that seamlessly blends opulence with transformative wellness. Each chateau within the collection will cater to the unique needs and aspirations of this elite clientele, providing a sanctuary where they can rejuvenate, recharge, and embark on a journey of self-discovery in the lap of luxury.

As part of its holistic approach to wellness, the Ultra-Elite Wellness Chateau Collection will integrate cutting-edge technology and visionary content aimed at empowering guests to achieve their full potential. Through immersive audiovisual experiences and mental programming for success, guests will be inspired to unlock new levels of performance, resilience, and fulfillment. By harnessing the power of luxury hospitality for positive social change, the Ultra-Elite Wellness Chateau Collection aims to leave a lasting legacy of wellness, prosperity, and philanthropy, empowering individuals to thrive in all aspects of their lives.

McWhorter Family Trust's visionary initiative underscores its unwavering commitment to excellence, innovation, and sustainability in the luxury hospitality industry. As guests embark on a transformative journey to wellness at the Trust's luxury wellness chateaus, they will be greeted with unparalleled luxury, personalized care, and a profound sense of well-being.

The McWhorter Family Trust is a visionary leader in luxury investment and philanthropy, dedicated to shaping a future where luxury and societal impact coexist harmoniously. With a deep-rooted commitment to excellence, innovation, and sustainability,

the Trust leverages cutting-edge technology and strategic investments to redefine luxury experiences and promote positive global impact.

Disclaimer, Disclosure & Legal Notice:
This press release is for informational purposes only and does not constitute legal, financial, or investment advice. It is not intended to provide specific recommendations, endorsements, or investment strategies. The information contained herein is subject to change without notice.

Regulatory Considerations:

This press release is not intended to constitute an offer to sell or the solicitation of an offer to buy securities. Any offers, sales, or purchases will be made in accordance with applicable securities laws and regulations. McWhorter Foundation has not registered with the U.S. Securities and Exchange Commission (SEC) and may operate under exemptions. Any investment decisions should be made in consultation with appropriate legal and financial advisors, considering the individual circumstances and objectives of potential investors.

Forward-Looking Statements:

Forward-looking statements involve inherent risks and uncertainties, and we caution you not to place undue reliance on forward-looking statements. We do not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. Actual results or outcomes may differ materially from those indicated or suggested by any forward-looking statements as a result of various factors, including, but not limited to, regulatory and legal developments, market conditions, and the outcome of negotiations. We disclaim any intention or obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

A photo accompanying this announcement is available at

To view this piece of content from, please give your consent at the top of this page.
To view this piece of content from, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Subsea7 awarded a contract for the Belinda field in the UK North Sea25.5.2024 14:01:09 CEST | Press release

Luxembourg – 25 May 2024 - Subsea7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) today announced the award of a sizeable1 contract by Serica Energy, for the Belinda field development south-east of the Triton FPSO. The Belinda field is operated by Serica Energy and located approximately 190 kilometres east of Aberdeen in the UK Central North Sea, with a water depth of 95 metres. The contract scope includes project management, engineering, procurement, construction and installation (EPCI) of a 5-kilometre 8” production pipeline with a 3” piggy-backed gas lift line and an electro-hydraulic controls (EHC) umbilical. Subsea7’s scope also includes associated subsea structures and tie-ins to the Triton Floating Production Storage & Offloading (FPSO) vessel operated by Dana Petroleum, via an existing production manifold near the Triton riser base and for controls at the Evelyn valve skid. Project management and engineering work will commence immediately in Aberdeen. The offshore activities are scheduled

Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further advancing company's IgA nephropathy (IgAN) portfolio25.5.2024 12:15:00 CEST | Press release

In the ALIGN study, atrasentan, in addition to supportive care with a renin-angiotensin system (RAS) inhibitor,demonstrated a statistically significant 36.1% proteinuria (protein in urine) reduction vs. placebo + supportive care at 36 weeks1 Endothelin A (ETA) receptor activation contributes to elevated proteinuria in IgAN2-5; atrasentan is a potent, selective ETA receptor antagonist with potential to reduce persistent proteinuria and preserve kidney function for a broad patient population1 IgAN is a heterogeneous, progressive, rare kidney disease with a need for effective, targeted therapies6,7; up to 30% of patients with persistent proteinuria (≥1 g/day) progress to kidney failure within 10 years8 Through its rare kidney disease portfolio, Novartis is committed to exploring a range of treatment options with different modes of action to slow IgAN progression Basel, May 25, 2024 – Novartis today presented results from a pre-specified interim analysis of the Phase III ALIGN study of atr

Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing clinically meaningful and statistically significant 35.1% proteinuria reduction vs. placebo25.5.2024 12:00:00 CEST | Press release

Secondary endpoint data for estimated glomerular filtration rate (eGFR) showed numerical improvement over 6 months vs. placebo1; additional 6-month open-label data to be presented at a future medical meeting2,3Fabhalta showed a favorable safety profile with no new safety signals1C3G, an ultra-rare kidney disease caused by alternative complement pathway overactivation, progresses to kidney failure in ∼50% of patients within 10 years4-7; currently there are no treatments approved for C3G7-9 Fabhalta, an oral Factor B inhibitor of the alternative complement pathway, selectively targets the underlying cause of C3G1; late-stage development program ongoing across several other rare diseases10-13 Basel, May 25, 2024 – Novartis today presented results from the 6-month, double-blind period of the Phase III APPEAR-C3G study of Fabhalta® (iptacopan) at the late-breaking clinical trials session of the European Renal Association (ERA) Congress1. Patients treated with Fabhalta in addition to support

Metasphere Labs Announces Development of Innovative Carbon Credit Protocol for Grid-Scale Batteries24.5.2024 22:05:00 CEST | Press release

VANCOUVER, British Columbia, May 24, 2024 (GLOBE NEWSWIRE) -- Metasphere Labs Inc. (formerly Looking Glass Labs Ltd., "Metasphere" or the "Company") (Cboe Canada: LABZ) (OTC: LABZF) (FRA: H1N) is excited to announce an innovative initiative aimed at accelerating the decarbonization of the electricity grid through the development of a pioneering carbon credit protocol for grid-scale batteries. Innovative Carbon Credit Protocol The Company is committed to leveraging advanced technology to address critical environmental challenges. The new carbon credit protocol will enable grid-scale batteries to monetize their environmental attributes by generating carbon credits for the carbon reductions achieved through optimized battery operations. This protocol is designed to incentivize the deployment and operation of grid-scale batteries, ensuring they play a pivotal role in the transition to a clean energy future. Submission to Pure Sky Carbon Credit Registry The Company intends to submit this pr

Nokia Corporation: Repurchase of own shares on 24.05.202424.5.2024 21:30:00 CEST | Press release

Nokia Corporation Stock Exchange Release 24 May 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 24.05.2024 Espoo, Finland – On 24 May 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL362,1533.55CEUX--BATE--AQEU--TQEX--Total362,1533.55 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 4 April 2023 started on 20 March 2024 and ends by 18 December 2024 with a maximum aggregate purchase price of EUR 300 million. Total cost of tra

HiddenA line styled icon from Orion Icon Library.Eye